dievini Hopp BioTech holding GmbH & Co. KG
  • Home
  • Management
  • Portfolio
  • Unternehmensmeldungen
  • Impressum
  • Datenschutz
  • English
dievini Hopp BioTech holding GmbH & Co. KG
  • Home
  • Management
  • Portfolio
  • Unternehmensmeldungen
  • Impressum
  • Datenschutz
  • English

28.07.2020: AC Immune SA

AC Immune Demonstrates Enhanced Performance of First-in-class Parkinson’s Diagnostic Agent

Next-generation PET tracer detects pathological alpha-synuclein with improved signal-to-noise ratio

Oral presentation at AAIC further demonstrates the strength of AC Immune’s Morphomer™ platform for generating highly selective small molecule diagnostics

AC Immune SA, a Swiss-based, clinical-stage biopharmaceutical company, with a broad pipeline focused on neurodegenerative diseases, today reported new data for its next generation alpha-synuclein positron emission tomography-(PET) tracer during an oral presentation at the Alzheimer’s Association International Conference (AAIC) and anticipates advancing its lead compound toward clinical stage development in Q4 2020.

Den gesamten Artikel lesen Sie bitte hier

AC Immune SA, News 2020
28.07.2020: Apogenix AG
29.07.2020: Cassiopea SpA

dievini Hopp BioTech holding GmbH & Co. KG | Impressum | Datenschutz